Liver Cirrhosis Completed Phase 4 Trials for Rifaximin (DB01220)

Also known as: Cirrhosis, Liver / Cirrhosis / Cirrhosis (of liver) NOS / Cirrhosis of liver / Cirrhosis liver / Hepatic cirrhosis NOS / Hepatic cirrhosis

IndicationStatusPhase
DBCOND0028911 (Liver Cirrhosis)Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01842581The Safety/Efficacy Of Rifaximin With/Without Lactulose In Subjects With A History Of Recurrent Hepatic EncephalopathyTreatment
NCT01769040Intestinal Decontamination With Rifaximin. The Inflammatory and Circulatory State in Patients With CirrhosisBasic Science